+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lunesta"

The U.S. Sleep Aids Market - Product Thumbnail Image

The U.S. Sleep Aids Market

  • Report
  • May 2021
  • 177 Pages
  • United States
From
Insomnia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Insomnia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • February 2023
  • 198 Pages
  • Global
From
Analyzing the Global CNS Market 2018 - Product Thumbnail Image

Analyzing the Global CNS Market 2018

  • Report
  • April 2018
  • Global
From
Lunesta - API Insight, 2022 - Product Thumbnail Image

Lunesta - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Lunesta- Drug Insight, 2019 - Product Thumbnail Image

Lunesta- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Lunesta (Eszopiclone) is a prescription medication used to treat insomnia. It is a central nervous system (CNS) drug, a type of drug that works by affecting the brain and nerves to produce a calming effect. Lunesta is classified as a sedative-hypnotic drug, meaning it is used to induce sleep and reduce anxiety. It is typically prescribed for short-term use, as long-term use can lead to dependence and tolerance. Lunesta is available in tablet form and is taken orally. It is typically taken at bedtime and should not be taken with alcohol or other CNS depressants. Common side effects of Lunesta include headache, dizziness, and drowsiness. The Lunesta market is part of the larger CNS drug market, which includes drugs used to treat a variety of conditions, such as anxiety, depression, and insomnia. The CNS drug market is highly competitive, with many companies offering similar products. Some of the companies in the Lunesta market include Sunovion Pharmaceuticals, Mylan Pharmaceuticals, and Teva Pharmaceuticals. Show Less Read more